medical technology

our projects

The project portfolio of Xlife Sciences AG is based on four pillars: technology platforms, biotech and therapies, medical technology and artificial intelligence. Our co-investors benefit from our unique selling proposition. In addition, our broad project portfolio offers adequate risk diversification.

clyxop devices GmbH

Medical Technology

The clyxop devices GmbH develops tubes, based on biocellulose that can be used as a bridging agent in cases of damage to hollow organs and stimulate tissue regeneration.

Learn more

Axenoll Life Sciences AG

Medical Technology

Axenoll develops and implements projects for cellular 3D screen printing of biomaterials for applications in the medical and biotechnological sector.

Learn more

saniva diagnostics GmbH

Medical Technology

saniva diagnostics specializes in developing a screening instrument for the early detection of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.

Learn more

Vitruvia Medical AG

Medical Technology

The Swiss investment company Vitruvia Medical AG invests in companies in the healthcare industry, focusing on medical devices.

Learn more

novaxomx GmbH

Medical Technology

The novaxomx GmbH is a joint venture between Curasan AG and Xlife Sciences AG. The aim is to research and develop exosomes for use in musculoskeletal diseases.

Learn more

Xsight Optics GmbH

Medical Technology

Xsight Optics is a German medical technology company based in Erfurt, Germany, founded in 2021 to establish itself as a new technology platform in the healthcare sector using artificial intelligence (AI)-based technology.

Learn more